Oki Mark K

Chief Financial Officer at ACHV; SVP, CFO and Sec at Alexza Pharmaceuticals Inc.

Sold, on record
$198k
Dollars the filings state
Form 4 sales
3
Latest Sep 18, 2025
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Alexza Pharmaceuticals Inc.Plan not stated
    Jun 6, 2012 2012

    Sold 31,873 shares at $0.34 ($11k)

    Oki Mark K, VP Fin Controller PAO PFO Sec

    Sold 18.8% of holdings ($58k position)137,896 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Alexza Pharmaceuticals Inc.Unusual
    Aug 27, 2012 +82 days

    Sold 10,000 shares at $4.14 ($41k)

    Oki Mark K, SVP, CFO and Sec

    Sold 72.5% of holdings ($57k position)3,788 shares leftFiling

  3. 3 Form 4 sale ACHVUnusual
    Sep 18, 2025 +4770 days

    Sold 50,060 shares at $2.92 ($146k)

    Oki Mark K, Chief Financial Officer

    No 10b5-1 planSold 28.1% of holdings ($520k position)127,940 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Oki Mark K
Source
Sep 18, 2025Sep 22, 2025ACHVChief Financial OfficerForm 4 sale50,060$146k28.1%UnusualSEC
Aug 27, 2012Aug 29, 2012Alexza Pharmaceuticals Inc.SVP, CFO and SecForm 4 sale10,000$41k72.5%UnusualSEC
Jun 6, 2012Jun 8, 2012Alexza Pharmaceuticals Inc.VP Fin Controller PAO PFO SecForm 4 sale31,873$11k18.8%Plan not statedSEC